News
With new diagnostic tools like AI-powered MRI and more personalized solutions like stem-cell therapies, the treatment ...
12h
The Times of Israel on MSNIn first, Israeli researchers develop mRNA jab against antibiotic-resistant bacteriumScientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid nanoparticles and shows 100% protection in animal models The post In first, Israeli ...
12h
The Brighterside of News on MSNBreakthrough mRNA vaccine shows 100% effectiveness against deadly bacteriaScientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...
The International Human Frontier Science Program Organization (HFSPO) is pleased to award the 2026 HFSP Nakasone Award to ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Explore more
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results